Physician profile
Michael J Subit
NPI 1619196037
$4,066.26
in general payments reported to CMS, 2019-2025
29 companies · $1,148 in 2025
The $1,148 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.02 · 2021: $234 · 2022: $725 · 2023: $1,646 · 2024: $301 · 2025: $1,148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,950 · Food and Beverage: $1,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,949.98 |
| Food and Beverage | $1,144.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $1,404.57 | 2023 | Gelpoint V-Path |
| Boston Scientific Corporation | $936.66 | 2025 | Axonics |
| Channel Medsystems, INC. | $497.03 | 2022-2024 | |
| Hologic Sales and Service, LLC | $161.61 | 2022-2024 | Myosure Tissue Removal Device, Acessa Provu System |
| Astellas Pharma US INC | $130.27 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $100.37 | 2021-2025 | Liletta |
| Meditrina | $99.39 | 2021-2023 | |
| Gynesonics, INC. | $92.69 | 2022 | |
| Becton, Dickinson and Company | $87.49 | 2021-2022 | |
| Sage Therapeutics, LLC | $82.32 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $59.91 | 2022-2025 | |
| Kerecis Limited | $51.75 | 2022 | |
| Optumhealth Care Solutions, LLC | $38.05 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Medtronic, INC. | $35.80 | 2025 | Interstim, Altaviva |
| Aspira Women'S Health INC | $32.67 | 2022-2024 | Ova1 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $28.43 | 2021-2024 | |
| Amgen INC. | $26.28 | 2019-2021 | |
| Alydia Health | $24.58 | 2021 | |
| Therapeuticsmd, INC. | $20.70 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.50 | 2023 | |
| Novo Nordisk INC | $18.70 | 2023 | |
| Agile Therapeutics, INC. | $18.49 | 2021 | |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Exact Sciences Corporation | $14.65 | 2023 | Cologuard Collection Kit |
| Allergan, INC. | $14.40 | 2021 | |
| Pfizer INC. | $13.95 | 2023 | |
| Coopersurgical, INC. | $13.50 | 2022 | |
| Smith+Nephew, INC. | $13.36 | 2022 | |
| Merck Sharp & Dohme LLC | $11.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Subit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.